Vitae Pharmaceuticals (VTAE) Priced

Developing small molecule drugs for type 2 diabetes and Alzheimer's.

Health Care - Biotechnology

IPO Performance
Latest Trade $21.00 0.00 (0.0%)
First Day Return -4.9%
Return from IPO 162.5%
 
Vitae Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 08/12/2014
Offer Price $8.00
Price Range $11.00 - $13.00
Offer Shares (mm) 6.9
Deal Size ($mm) 55
 
IPO Data
IPO Date 09/24/2014
Offer Price $8.00
Price Range $11.00 - $13.00
Offer Shares (mm) 6.9
Deal Size ($mm) $55
 
Underwriters
more
Business Overview
Developing small molecule drugs for type 2 diabetes and Alzheimer's.
Developing small molecule drugs for type 2 diabetes and Alzheimer's.
more
Company Data
Headquarters Fort Washington, PA
Founded 2001
Employees 52
Website www.vitaepharma.com
 

Performance vs. IPO Index (IPOUSA)